Crossmark

Overcoming challenges to reduce time to antibiotic therapy in febrile neutropenic children: insights from a Mexican center

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.04.123

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Colunga-Pedraza, Julia Esther https://orcid.org/0000-0001-7933-094X
Lopez-Reyna, Ingrid Gabriela https://orcid.org/0000-0001-5257-4733
Vaquera-Aparicio, Denisse Natalie https://orcid.org/0000-0002-3181-7983
Peña-Lozano, Samantha Paulina https://orcid.org/0000-0002-6354-887X
Arrieta, Jafet https://orcid.org/0000-0002-5963-9461
Hernández-Torres, Lucía Elizabeth https://orcid.org/0009-0009-5707-0935
Colunga-Pedraza, Perla Rocío https://orcid.org/0000-0002-9937-439X
Regalado, Mónica https://orcid.org/0009-0006-6337-3017
Jiménez-Antolinez, Yajaira Valentine https://orcid.org/0000-0002-7988-8094
García-Rodríguez, Fernando https://orcid.org/0000-0001-9276-0725
González-Llano, Oscar https://orcid.org/0000-0001-7638-5590
Funding

Funding for this research was provided by:

Instituto de Ciencias del Mar y Limnología, Universidad Nacional Autónoma de México
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-08-08
More Information

This article is maintained by: Elsevier

Article Title: Overcoming challenges to reduce time to antibiotic therapy in febrile neutropenic children: insights from a Mexican center

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.04.123

Content Type: article

Copyright: © 2024 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.

Document is current

Any future updates will be listed below